East African Community2023-07-312023-07-312022East African Community. (2022). EAC pharmaceutical manufacturing. EAC Secretariathttps://doi.org/10.60682/6jhp-hb58Policy briefThe pharmaceutical manufacturing landscape in East Africa is rapidly transforming with an estimated market size of USD 3 billion (this is set to be even higher with entry of DRC in to the Community) and Compound Annual Growth Rate (CAGR) of 12%. New investments and expansion of existing facilities are ongoing in all the EAC Partner States. The region is implementing policies and strategies that are aimed at promoting local production of medicines. These include the second EAC Pharmaceutical Manufacturing Plan of Action (EAC RPMPOA 2017-2027) and the Medicines and Health Technologies Policy and Strategic Plan (2016-2021). In addition, the EAC Industrialization Policy and Strategy (2010-2030) has prioritized pharmaceutical manufacturing as one of the six key strategic industries for collective support. All EAC Partner States have established semi-autonomous regulatory agencies.enOther